Tidal Investments LLC Grows Stock Holdings in Pediatrix Medical Group, Inc. $MD

Tidal Investments LLC raised its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 253.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 616,048 shares of the company’s stock after acquiring an additional 441,959 shares during the quarter. Tidal Investments LLC owned about 0.76% of Pediatrix Medical Group worth $15,604,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at $347,383,000. Dimensional Fund Advisors LP grew its holdings in Pediatrix Medical Group by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock valued at $82,496,000 after buying an additional 287,696 shares in the last quarter. California State Teachers Retirement System increased its position in shares of Pediatrix Medical Group by 3,906.1% during the second quarter. California State Teachers Retirement System now owns 3,282,109 shares of the company’s stock valued at $83,136,000 after buying an additional 3,200,181 shares during the period. Wasatch Advisors LP increased its position in shares of Pediatrix Medical Group by 21.9% during the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock valued at $63,297,000 after buying an additional 448,360 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Pediatrix Medical Group by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 2,181,712 shares of the company’s stock worth $46,674,000 after buying an additional 14,421 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

MD has been the subject of a number of analyst reports. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and raised their price objective for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Truist Financial increased their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Wall Street Zen downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. UBS Group upped their price target on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Finally, Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $26.60.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $26.68 on Friday. The firm has a market capitalization of $2.17 billion, a PE ratio of 12.77 and a beta of 0.64. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group, Inc. has a 12 month low of $15.69 and a 12 month high of $27.94. The business’s 50-day moving average price is $26.42 and its 200-day moving average price is $23.57.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.04. The business had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.Pediatrix Medical Group’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.53 earnings per share. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.